Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study

por Kaljouw, Sylvia, Jansen, Erik E. L., Aitken, Clare A., de Kok, Inge M. C. M.
Publicado 2022

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study

por Jansen, Erik E. L., de Kok, Inge M. C. M., Kaljouw, Sylvia, Demirel, Erhan, de Koning, Harry J., Hontelez, Jan. A. C.
Publicado 2022

Effects of cancer screening restart strategies after COVID-19 disruption

por Kregting, Lindy M., Kaljouw, Sylvia, de Jonge, Lucie, Jansen, Erik E. L., Peterse, Elisabeth F. P., Heijnsdijk, Eveline A. M., van Ravesteyn, Nicolien T., Lansdorp-Vogelaar, Iris, de Kok, Inge M. C. M.
Publicado 2021

Correction: Effects of cancer screening restart strategies after COVID-19 disruption

por Kregting, Lindy M., Kaljouw, Sylvia, de Jonge, Lucie, Jansen, Erik E. L., Peterse, Elisabeth F. P., Heijnsdijk, Eveline A. M., van Ravesteyn, Nicolien T., Lansdorp-Vogelaar, Iris, de Kok, Inge M. C. M.
Publicado 2021

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe

por Gini, Andrea, Buskermolen, Maaike, Senore, Carlo, Anttila, Ahti, Novak Mlakar, Dominika, Veerus, Piret, Csanádi, Marcell, Jansen, Erik E. L., Zielonke, Nadine, Heinävaara, Sirpa, Széles, György, Segnan, Nereo, de Koning, Harry J., Lansdorp-Vogelaar, Iris
Publicado 2021

Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analy...

por Smith, Megan A., Burger, Emily A., Castanon, Alejandra, de Kok, Inge M.C.M., Hanley, Sharon J.B., Rebolj, Matejka, Hall, Michaela T., Jansen, Erik E.L., Killen, James, O'Farrell, Xavier, Kim, Jane J., Canfell, Karen
Publicado 2021

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy

por Aitken, Clare A., Siebers, Albert G., Matthijsse, Suzette M., Jansen, Erik E. L., Bekkers, Ruud L. M., Becker, Jeroen H., ter Harmsel, Bram, Roovers, Jan‐Paul W. R., van Kemenade, Folkert J., de Kok, Inge M. C. M.
Publicado 2019

The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe

por Gini, Andrea, van Ravesteyn, Nicolien T., Jansen, Erik E.L., Heijnsdijk, Eveline A.M., Senore, Carlo, Anttila, Ahti, Novak Mlakar, Dominika, Veerus, Piret, Csanádi, Marcell, Zielonke, Nadine, Heinävaara, Sirpa, Széles, György, Segnan, Nereo, de Koning, Harry J., Lansdorp-Vogelaar, Iris
Publicado 2021

Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptions

por Burger, Emily A., de Kok, Inge M.C.M., O’Mahony, James F, Rebolj, Matejka, Jansen, Erik E.L., de Bondt, Daniel D., Killen, James, Hanley, Sharon J., Castanon, Alejandra, Kim, Jane J., Canfell, Karen, Smith, Megan A., Regan, Mary Caroline
Publicado 2022